Your browser doesn't support javascript.
loading
Characteristics and outcomes of multisystem inflammatory syndrome in children: A multicenter, retrospective, observational cohort study in Mexico.
Yamazaki-Nakashimada, Marco Antonio; Márquez-González, Horacio; Miranda-Novales, Guadalupe; Neme Díaz, Gonzalo Antonio; Prado Duran, Sandhi Anel; Luévanos Velázquez, Antonio; Castilla-Peon, Maria F; González-García, Nadia; Sánchez Duran, Miguel Alejandro; Márquez Aguirre, Martha Patricia; Villasis-Keever, Miguel Angel; Aragón Nogales, Ranferi; Núñez-Enríquez, Juan Carlos; Martinez Bustamante, Maria Elena; Aguilar Argüello, Carlos; Ramírez de Los Santos, Jesús; Pérez Barrera, Alejandra; Palacios Cantú, Lourdes Anais; Membrila Mondragón, Jesús; Vizcarra Alvarado, Paloma; Jiménez Juárez, Rodolfo Norberto; Olivar López, Víctor; Velasco-Segura, Roberto; López Chávez, Adrián.
Afiliação
  • Yamazaki-Nakashimada MA; National Institute of Pediatrics, Mexico City, Mexico.
  • Márquez-González H; Department of Rheumatology, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico.
  • Miranda-Novales G; XXI Century National Medical Center, Mexican Social Security Institute, Mexico City, Mexico.
  • Neme Díaz GA; Hospital del Niño Dr. Rodolfo Nieto Padrón, Villahermosa, Mexico.
  • Prado Duran SA; Mexican Social Security Institute (IMSS), Mexico City, Mexico.
  • Luévanos Velázquez A; Civil Hospital of Guadalajara, Guadalajara, Mexico.
  • Castilla-Peon MF; Hospital Psiquiatrico Infantil Juan N Navarro, Servicios de Atención Psiquiátrica, Mexico City, Mexico.
  • González-García N; Department of Rheumatology, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico.
  • Sánchez Duran MA; National Institute of Pediatrics, Mexico City, Mexico.
  • Márquez Aguirre MP; National Institute of Pediatrics, Mexico City, Mexico.
  • Villasis-Keever MA; XXI Century National Medical Center, Mexican Social Security Institute, Mexico City, Mexico.
  • Aragón Nogales R; XXI Century National Medical Center, Mexican Social Security Institute, Mexico City, Mexico.
  • Núñez-Enríquez JC; XXI Century National Medical Center, Mexican Social Security Institute, Mexico City, Mexico.
  • Martinez Bustamante ME; Centro Médico Nacional 20 de Noviembre (CMN), Mexico City, Mexico.
  • Aguilar Argüello C; Hospital del Niño Dr. Rodolfo Nieto Padrón, Villahermosa, Mexico.
  • Ramírez de Los Santos J; Hospital del Niño Dr. Rodolfo Nieto Padrón, Villahermosa, Mexico.
  • Pérez Barrera A; Hospital del Niño Dr. Rodolfo Nieto Padrón, Villahermosa, Mexico.
  • Palacios Cantú LA; Mexican Social Security Institute (IMSS), Mexico City, Mexico.
  • Membrila Mondragón J; Mexican Social Security Institute (IMSS), Mexico City, Mexico.
  • Vizcarra Alvarado P; Civil Hospital of Guadalajara, Guadalajara, Mexico.
  • Jiménez Juárez RN; Department of Rheumatology, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico.
  • Olivar López V; Department of Rheumatology, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico.
  • Velasco-Segura R; Instituto de Ciencias Aplicada y Tecnología, Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • López Chávez A; Department of Rheumatology, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico.
Front Pediatr ; 11: 1167871, 2023.
Article em En | MEDLINE | ID: mdl-37274824
ABSTRACT

Introduction:

Multisystem inflammatory syndrome in children associated with coronavirus disease 2019 (MIS-C), a novel hyperinflammatory condition secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is associated with severe outcomes such as coronary artery aneurysm and death.

Methods:

This multicenter, retrospective, observational cohort study including eight centers in Mexico, aimed to describe the clinical characteristics and outcomes of patients with MIS-C. Patient data were evaluated using latent class analysis (LCA) to categorize patients into three phenotypes toxic shock syndrome-like (TSSL)-MIS-C, Kawasaki disease-like (KDL)-MIS-C, and nonspecific MIS-C (NS-MIS-C). Risk factors for adverse outcomes were estimated using multilevel mixed-effects logistic regression.

Results:

The study included 239 patients with MIS-C, including 61 (26%), 70 (29%), and 108 (45%) patients in the TSSL-MIS-C, KDL-MIS-C, and NS-MIS-C groups, respectively. Fifty-four percent of the patients were admitted to the intensive care unit, and 42%, 78%, and 41% received intravenous immunoglobulin, systemic glucocorticoids, and anticoagulants, respectively. Coronary artery dilatation and aneurysms were found in 5.7% and 13.2% of the patients in whom coronary artery diameter was measured, respectively. Any cause in-hospital mortality was 5.4%. Hospitalization after ten days of symptoms was associated with coronary artery abnormalities (odds ratio [OR] 1.6, 95% confidence interval [CI] 1.2-2.0). Age ≥10 years (OR 5.6, 95% CI 1.4-2.04), severe underlying condition (OR 9.3, 95% CI 2.8-31.0), platelet count <150,000 /mm3 (OR 4.2, 95% CI 1.2-14.7), international normalized ratio >1.2 (OR 3.8, 95% CI 1.05-13.9), and serum ferritin concentration >1,500 mg/dl at admission (OR 52, 95% CI 5.9-463) were risk factors for death.

Discussion:

Mortality in patients with MIS-C was higher than reported in other series, probably because of a high rate of cases with serious underlying diseases.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies País/Região como assunto: Mexico Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies País/Região como assunto: Mexico Idioma: En Ano de publicação: 2023 Tipo de documento: Article